Research Article
High Thyroglobulin Antibody Levels Increase the Risk of Differentiated Thyroid Carcinoma
Table 1
Clinical characteristics of the final study cohort.
| | | DTC | Benign | value |
| | Number () | 237 | 1,401 | | | Gender (, %) | | | 0.209 | | Male () | 44 (18.6) | 311 (22.2) | | | Female ( = 1,283) | 193 (81.4) | 1,090 (77.8) | | | Mean age (yr) | 43.4 ± 12.9 | 48.4 ± 11.1 | <0.001 | | Median TSH (mIU/L) | 1.53 (0.88–2.42) | 1.05 (0.64–1.78) | <0.001 | | Mean nodule size (cm) | 2.7 ± 1.9 | 3.3 ± 1.6 | <0.001 | | Nodule type (, %) | | | <0.001 | | Solitary () | 80 (33.8) | 241 (17.2) | | | Multiple ( = 1,317) | 157 (66.2) | 1,160 (82.8) | | | TgAb ≥ 40 IU/mL () | 56 (23.6) | 177 (12.6) | <0.001 | | TPOAb ≥ 50 IU/mL () | 30 (12.7) | 106 (7.6) | 0.009 |
|
|
TSH levels are presented as median (25th–75th empirical percentiles).
DTC: differentiated thyroid cancer.
|
